ruthenium has been researched along with Experimental Mammary Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, T; Roy, S; Sil, A | 1 |
| Cheng, H; Li, RQ; Qiu, WX; Xie, BR; Yu, WY; Zhang, C; Zhang, XZ | 1 |
| Che, CM; Kwong, WL; Lai, YT; Lam, KY; Lee, PY; Lok, CN | 1 |
| Alessio, E; Bergamo, A; Cocchietto, M; Gava, B; Mestroni, G; Sava, G; Serli, B; Zorzet, S | 1 |
| Bergamo, A; Cocchietto, M; DiGiovine, S; Garbisa, S; Pezzoni, G; Sartor, L; Sava, G; Soranzo, M; Turrin, C; Vita, F; Zabucchi, G; Zorzet, S | 1 |
| Bacac, M; Castellarin, A; Cocchietto, M; Gava, B; Pacor, S; Sava, G; Turrin, C; Vadori, M; Zorzet, S | 1 |
| Bergamo, A; Brescacin, L; Cocchietto, M; Delfino, R; Dyson, PJ; Geldbach, TJ; Laurenczy, G; Sava, G; Scolaro, C | 1 |
| Giraldi, T; Mestroni, G; Sava, G; Zassinovich, G; Zorzet, S | 1 |
| Atkins, HL; Brill, AB; Guglielmi, G; Matsui, K; Oster, ZH; Pellettieri, ML; Persson, BR; Richards, P; Som, P; Srivastava, SC | 1 |
| Alessio, E; Bergamo, A; Capozzi, I; Cocchietto, M; Mestroni, G; Sava, G | 1 |
| Alessio, E; Capozzi, I; Clerici, K; Gagliardi, G; Mestroni, G; Sava, G | 1 |
| Alessio, E; Capozzi, I; Clerici, K; Cocchietto, M; Gagliardi, R; Mestroni, G; Perbellini, A; Sava, G | 1 |
| Alessio, E; Bergamo, A; Boccarelli, A; Coluccia, M; Iengo, E; Sava, G; Zorzet, S | 1 |
| Alessio, E; Bregant, F; Ceschia, V; Mestroni, G; Pacor, S; Sava, G | 1 |
14 other study(ies) available for ruthenium and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Potentiating apoptosis and modulation of p53, Bcl2, and Bax by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Female; Flavonoids; Humans; Male; Mammary Neoplasms, Experimental; MCF-7 Cells; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Ruthenium; Tumor Suppressor Protein p53 | 2019 |
A two-photon excited O
Topics: Animals; Cell Line, Tumor; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanocomposites; Nitriles; Photochemotherapy; Photosensitizing Agents; Ruthenium; Singlet Oxygen; Tumor Hypoxia; Tumor Microenvironment | 2019 |
A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Macrocyclic Compounds; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neovascularization, Pathologic; Ruthenium; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2016 |
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dimethyl Sulfoxide; G2 Phase; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mitosis; Neoplasm Invasiveness; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Tumor Cells, Cultured | 2002 |
Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Adhesion; Cell Division; Collagen; Collagen Type IV; Dimethyl Sulfoxide; Drug Combinations; Female; Humans; Kidney; Laminin; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Invasiveness; Organometallic Compounds; Proteoglycans; Ruthenium; Ruthenium Compounds; Tumor Cells, Cultured | 2003 |
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
Topics: Animals; Dimethyl Sulfoxide; Female; Hyaluronan Receptors; Injections, Intralesional; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Ruthenium Compounds | 2004 |
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Topics: Adamantane; Animals; Antineoplastic Agents; Benzene Derivatives; Buffers; Cell Line, Tumor; DNA; Female; Humans; Hydrolysis; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Sodium Chloride; Solutions; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2005 |
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Ruthenium | 1984 |
97Ru-transferrin uptake in tumor and abscess.
Topics: Abscess; Adenocarcinoma; Animals; Gallium Radioisotopes; Glioma; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Rabbits; Radioisotopes; Ruthenium; Transferrin; Turpentine | 1983 |
Treatment of residual metastases with Na[trans-RuCl4 (DMSO)lm] and ruthenium uptake by tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm, Residual; Organometallic Compounds; Ruthenium; Survival Analysis | 1996 |
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Female; Flow Cytometry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Ruthenium | 1998 |
Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Lewis Lung; Cell Cycle; Dimethyl Sulfoxide; Female; Flow Cytometry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred Strains; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Spectrophotometry, Atomic; Tissue Distribution | 1999 |
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[[trans-RuCl4(Me2SO)]2(mu-L)] (L = ditopic, non-chelating aromatic N-ligand). A preliminary investigation.
Topics: Animals; Antineoplastic Agents; Dimerization; DNA; Female; Ligands; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium | 2000 |
Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].
Topics: Animals; Antineoplastic Agents; Carcinoma; Cisplatin; Imidazoles; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Organometallic Compounds; Ruthenium; Survival Analysis | 1991 |